Tacrolimus reduces staphylococcal colonization on the skin in Korean atopic dermatitis patients

Drugs under Experimental and Clinical Research

Volumn 31, Issue 2, 2005, Pages 77-87

  Park, Chun Wook ^a   Lee, B H ^a   Lee, C H ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; SKIN; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; TIME; WATER LOSS; BACTERIAL COUNT; CHILD; CLINICAL TRIAL; ECZEMA; GROWTH, DEVELOPMENT AND AGING; LUNG GAS EXCHANGE; MICROBIOLOGY; PRESCHOOL CHILD; SEASON; STAPHYLOCOCCUS; THERMOREGULATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; BLOOD-AIR BARRIER; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DERMATITIS, ATOPIC; ECZEMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SEASONS; SKIN; STAPHYLOCOCCUS; TACROLIMUS; WATER LOSS, INSENSIBLE;

EID: 23244465895     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ogawa T., Katsuoka K., Kawano K., Nishiyama S. Comparative study of staphylococcal flora on the skin surface of atopic dermatitis patients and healthy subjects. J. Dermatol., 21, 453, 1994.
2. Leung D.Y.M. Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic disease. J. Allergy Clin. Immunol., 96, 301, 1995.
3. Matsoi K., Nishikawa A., Suto H., Tsuboi R., Ogawa H. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients. Microbiol. Immunol., 44, 945, 2000.
4. Breuer K., Häussler S., Kapp A., Werfel T. Staphylococcus aureus: Colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol., 147, 55, 2002.
5. Adachi Y., Akamatsu H., Horio T. The effect of antibiotics on the production of superantigen from staphylococcus isolated from atopic dermatitis. J. Dermatol. Science, 28, 76, 2002.
6. Won C.H., Seo P.G., Park Y.M., et al. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea. J. Dermatol. Treatment, 14, 1, 2003.
7. Ruzicka T., Reitamo S. Tacrolimus ointment. First Edition. Springer, New York, 2004, pp. 86-90.
8. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Ach. Dermatol. Venerol. (Stockh). 92(Suppl.), 44, 1989.
9. Rajka G., Langeland T. Grading of the severity of atopic dermatitis. Acta. Derm. Venereol. (Stockh), 144(Suppl.), 13, 1989.
10. Hanifin J.M., Thurston M., Omoto M., et al. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. Exp. Dermatol., 10, 11, 2001.
11. Updegraff D.M. A cultural method of quantitatively studying the microorganisms in the skin. J. Invest. Dermatol., 43, 129, 1964.
12. Pinnagoda J., Tupker R.A., Agner T., Serup J. Guideline for transepidermal water loss (TEWL) measurement. Contact Dermatitis, 22, 164, 1990.
13. Higaki S., Morohashi M., Yamagishi T., Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int. J. Dermatol., 38, 265, 1999.
14. Leung D.Y.M. Infection in atopic dermatitis. Curr. Opin. Pediatr., 15, 399, 2003.
15. Patel G.K., Wyatt H., Kubiak E.M., Clark S.M., Mills C.M. Staphylococcus aureus colonization of children with atopic eczema and their parents. Acta. Derm. Venerol. (Stockh), 81, 366, 2001.
16. Williams R.E.A. The antibacterial-corticosteroid combination. Am. J. Clin. Dermatol., 1, 211, 2000.
17. Taskapan M.O., Kumar P. Role of staphylococcal superantigens in atopic dermatitis: From colonization to inflammation. Ann. Allergy Asthma Immunol., 84, 3, 2000.
18. Capoluongo E., Giglio A., Lavieri M.M., et al. Genotypic and phenotypic characterization of Staphylococcus aureus strain isolated in subjects with atopic dermatitis. Higher prevalence of exfoliative B toxin production in lesional strains and correlation between the markers of disease intensity and colonization density. J. Dermatol. Science, 26, 145, 2001.
19. Abeck D., Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br. J. Dermatol. 139, 13, 1998.
20. Traver J.B., Norms D.A., Leung D.Y.M. The keratinocyte as a target for staphylococcal bacterial toxins. J. Invest. Dermatol. Symposium Proceedings, 6, 225, 2001.
21. Sugimoto K., Ishikawa N., Sugioka T., et al. The importance of disinfection therapy using povidone-iodine solution in atopic dermatitis. Dermatol., 204(Suppl.), 63, 2002.
22. Arkwright P.D., Daniel T.O., Sanyal D., David T.J., Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch. Dermatol., 138, 939, 2002.
23. Nilsson E.J., Henning C.G., Magnusson J., Sundsvall. Topical corticosteroid and Staphylococcus aureus in atopic dermatitis. J. Am. Acad. Dermatol., 27, 29, 1992.
24. Stalder J.F., Fleury M., Sourisse M., Rostin M., Pheline F., Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br. J. Dermatol., 131, 536, 1994.
25. Hauk P.J., Hamid Q.A., Chrousos G.P., Leung D.Y.M. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. Allergy Clin. Immunol., 105, 782, 2000.
26. Leung D.Y.M., Hamid Q.A., Vottero A., et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor. J. Exp. Med., 186, 1567, 1997.
27. Hauk P.J., Leung D.Y.M. Tacrolimus (FK506): New treatment approach in superantigen-associated diseases like atopic dermatitis? J. Allergy Clin. Immunol., 107, 391, 2001.
28. Tsytsykova A.V., Goldfeld A.E. Nuclear factor of activated T cells transcription factor NFATp controls superantigen-induced lethal shock. J. Exp. Med., 192, 581, 2000.
29. Pournaras C.C., Lübbe J., Saurat J.H. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FK506). J. Invest. Dermatol., 116, 480, 2001.
30. Aaltokorte K. Improvement of skin barrier function during treatment of atopic dermatitis. J. Am. Acad. Dermatol., 33, 969, 1995.
31. Remitz A., Kyllönen H., Granlund H., Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J. Allergy Clin. Immunol., 107, 196, 2001.
32. Bieber T. Topical tacrolimus (FK506): A new milestone in the management of atopic dermatitis. J. Allergy. Clin. Immunol., 102, 555, 1998.
33. Blank I.H., Dawes R.K. Identification of coagulase-negative staphylococci with the API staph system. J. Clin. Microb., 16, 874, 1982.
34. Reitamo S., Wollenberg A., Schopf E., et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch. Dermatol., 136, 999, 2000.